Humana Inc. $HUM Stock Sold by North Dakota State Investment Board

North Dakota State Investment Board cut its holdings in Humana Inc. (NYSE:HUM) by 29.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,425 shares of the insurance provider’s stock after selling 2,213 shares during the quarter. North Dakota State Investment Board’s holdings in Humana were worth $2,070,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Johnson Financial Group Inc. bought a new stake in shares of Humana in the 2nd quarter valued at $26,000. Trust Co. of Vermont acquired a new position in shares of Humana during the 2nd quarter valued at $28,000. Bogart Wealth LLC boosted its stake in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. MidFirst Bank bought a new position in Humana during the second quarter worth $35,000. Finally, Global Assets Advisory LLC bought a new position in Humana during the first quarter worth $38,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on HUM. Barclays increased their price objective on shares of Humana from $515.00 to $582.00 and gave the stock an “overweight” rating in a research report on Friday, October 9th. Raymond James Financial raised Humana from a “market perform” rating to an “outperform” rating and set a $520.00 target price for the company in a research report on Monday, October 12th. Wolfe Research reaffirmed an “outperform” rating and set a $450.00 price target on shares of Humana in a research note on Monday, August 24th. Mizuho upped their price target on Humana from $468.00 to $495.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 13th. Finally, Citigroup initiated coverage on Humana in a report on Friday, October 9th. They issued a “buy” rating on the stock. Twenty-one equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $453.30.

Humana Stock Up 0.9%

Shares of NYSE HUM opened at $415.55 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company has a 50-day moving average price of $400.25 and a 200-day moving average price of $308.01. The stock has a market capitalization of $49.90 billion, a P/E ratio of 39.31, a P/E/G ratio of 2.54 and a beta of 0.74. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $456.50.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the prior year, the business posted $6.27 EPS. The firm’s revenue was up 26.2% compared to the same quarter last year. On average, equities research analysts forecast that Humana Inc. will post 9.03 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be issued a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s payout ratio is currently 33.49%.

Humana Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.